The Conversation (0)
- WORLD EDITIONAustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
Top Stocks
Top Resource Stocks
Top Tech Stocks
Top Life Science Stocks
Trending
Trending Articles
Trending Press Releases
Trending Companies
Trending Reports
Resource
Popular Lists
Investing Ideas
Outlook Reports
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
Investing Guides
Tech
Popular Lists
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
Investing Ideas
Outlook Reports
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
Investing Guides
Life Science
Popular Lists
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
Outlook Reports
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Investing Guides
Scythian Biosciences Corp. Announces Approval for Listing on the Nasdaq Capital Markets
Feb. 14, 2018 09:51AM PST
Biotech InvestingScythian Biosciences (TSXV:SCYB) is pleased to announce that the Company has received approval from the Nasdaq Capital Market to list its common shares on the Nasdaq. In honour of the listing, Scythian will ring the closing bell at the Nasdaq MarketSite in Times Square, New York City on February 22, 2018. As quoted in the press release: …
Scythian Biosciences (TSXV:SCYB) is pleased to announce that the Company has received approval from the Nasdaq Capital Market to list its common shares on the Nasdaq. In honour of the listing, Scythian will ring the closing bell at the Nasdaq MarketSite in Times Square, New York City on February 22, 2018.
As quoted in the press release:
The common shares of the Company will commence trading on the Nasdaq at the opening of trading on February 22, 2018, under the trading symbol “SCYB”.
Jonathan Gilbert, Scythian’s CEO, commented, “We are pleased to have completed this major milestone. The Nasdaq listing represents greater accessibility and liquidity to a broader group of investors and increased market recognition, while our dual listing on the TSXV provides continued access to the investment community in Canada.”
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.